Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005) ; volume:7 ; number:1 ; day:18 ; month:4 ; year:2007 ; pages:1-9 ; date:12.2007
BMC infectious diseases ; 7, Heft 1 (18.4.2007), 1-9, 12.2007
- Creator
-
Sader, Hélio S.
- Contributor
-
Watters, Amy A.
Fritsche, Thomas R.
Jones, Ronald N.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2334-7-29
- URN
-
urn:nbn:de:1111-2016030250869
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
06.11.2025, 10:36 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sader, Hélio S.
- Watters, Amy A.
- Fritsche, Thomas R.
- Jones, Ronald N.
- SpringerLink (Online service)
Other Objects (12)
Economic burden of nosocomial infections caused by vancomycin-resistant enterococci
Emergence of vancomycin-resistant enterococci in Switzerland: a nation-wide survey
Vancomycin-lipopeptide conjugates with high antimicrobial activity on vancomycin-resistant enterococci
Repurposing auranofin as an intestinal decolonizing agent for vancomycin-resistant enterococci
P067: Economic burden of methicillin-resistant Staphylococcus aureus, Clostridium difficile, and vancomycin-resistant enterococci in hospitals
Lactobacillus-derived extracellular vesicles enhance host immune responses against vancomycin-resistant enterococci
Oral vancomycin use and incidence of vancomycin-resistant enterococci: time-series analysis
Donor-derived vancomycin-resistant enterococci transmission and bloodstream infection after intestinal transplantation
Correction to: The Increasing Issue of Vancomycin-Resistant Enterococci and the Bacteriocin Solution
Confounding by indication affects antimicrobial risk factors for methicillin-resistant Staphylococcus aureus but not vancomycin-resistant enterococci acquisition
P064: Direct identification of vancomycin-resistant enterococci from selective enrichment broth by mass spectrometry
Risk factors for gut colonization with vancomycin-resistant enterococci among Bulgarian critically ill patients
Economic burden of nosocomial infections caused by vancomycin-resistant enterococci
Emergence of vancomycin-resistant enterococci in Switzerland: a nation-wide survey
Vancomycin-lipopeptide conjugates with high antimicrobial activity on vancomycin-resistant enterococci
Repurposing auranofin as an intestinal decolonizing agent for vancomycin-resistant enterococci
P067: Economic burden of methicillin-resistant Staphylococcus aureus, Clostridium difficile, and vancomycin-resistant enterococci in hospitals
Lactobacillus-derived extracellular vesicles enhance host immune responses against vancomycin-resistant enterococci
Oral vancomycin use and incidence of vancomycin-resistant enterococci: time-series analysis
Donor-derived vancomycin-resistant enterococci transmission and bloodstream infection after intestinal transplantation
Correction to: The Increasing Issue of Vancomycin-Resistant Enterococci and the Bacteriocin Solution
Confounding by indication affects antimicrobial risk factors for methicillin-resistant Staphylococcus aureus but not vancomycin-resistant enterococci acquisition
P064: Direct identification of vancomycin-resistant enterococci from selective enrichment broth by mass spectrometry
Risk factors for gut colonization with vancomycin-resistant enterococci among Bulgarian critically ill patients
Economic burden of nosocomial infections caused by vancomycin-resistant enterococci
Emergence of vancomycin-resistant enterococci in Switzerland: a nation-wide survey
Vancomycin-lipopeptide conjugates with high antimicrobial activity on vancomycin-resistant enterococci
Repurposing auranofin as an intestinal decolonizing agent for vancomycin-resistant enterococci
P067: Economic burden of methicillin-resistant Staphylococcus aureus, Clostridium difficile, and vancomycin-resistant enterococci in hospitals
Lactobacillus-derived extracellular vesicles enhance host immune responses against vancomycin-resistant enterococci
Oral vancomycin use and incidence of vancomycin-resistant enterococci: time-series analysis
Donor-derived vancomycin-resistant enterococci transmission and bloodstream infection after intestinal transplantation
Correction to: The Increasing Issue of Vancomycin-Resistant Enterococci and the Bacteriocin Solution
Confounding by indication affects antimicrobial risk factors for methicillin-resistant Staphylococcus aureus but not vancomycin-resistant enterococci acquisition
P064: Direct identification of vancomycin-resistant enterococci from selective enrichment broth by mass spectrometry